ONO Pharmaceutical Co. Ltd.
Japanese drugmaker Ono Pharmaceutical excels in oncology with Opdivo and Kyprolis, expanding into rare diseases, diabetes, heart failure, and CNS disorders, supported by collaborations with Adimab, Turbine, and Harvard that fuel its global growth.
Headquarters: Japan (JPN)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Manufacturing
- Industry: Pharmaceutical Manufacturing
- Employees: 4,287
- HQ: Osaka
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.